Ensol Biosciences Inc. (XKON:140610)
13,750
-150 (-1.08%)
At close: Apr 28, 2026
Ensol Biosciences Market Cap
Ensol Biosciences has a market cap or net worth of 186.26 billion as of April 29, 2026. Its market cap has decreased by -35.31% in one year.
Market Cap
186.26B
Enterprise Value
n/a
Revenue
537.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
13,750.00
Market Cap Chart
Since September 10, 2018, Ensol Biosciences's market cap has increased from 106.21B to 186.26B, an increase of 75.38%. That is a compound annual growth rate of 7.63%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prestige Biologics | 185.83B |
| ISU Abxis | 201.00B |
| QuadMedicine | 164.54B |
| Genome & Company | 221.57B |
| ViGenCell | 226.93B |
| ABION | 236.52B |
| CORESTEMCHEMON | 144.84B |
| BIO-FD&C | 125.48B |